Mandy Abram
Medical · Orchard Park, NYNPI 1447547310
Payments from drug & device makers
Across 190 payments — averaging $56.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pentax Of America, Inc.$7K
- AbbVie$476
- Lilly USA, LLC$448
- AstraZeneca$305
- Pfizer$223
- Novo Nordisk$203
- plus $2K from 27 others
What the payments were for
- Food & beverage$3,10829%
- Education$661%
- Other$7,46870%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pentax Of America, Inc. | 27 | $7,468 |
| AbbVie | 23 | $476 |
| Lilly USA, LLC | 27 | $448 |
| AstraZeneca | 17 | $305 |
| Pfizer | 13 | $223 |
| Novo Nordisk | 11 | $203 |
| Boehringer Ingelheim | 9 | $170 |
| Amgen | 9 | $158 |
| Gilead | 2 | $144 |
| GSK | 6 | $103 |
| Astellas Pharma US Inc | 2 | $100 |
| Merck | 5 | $99 |
| Exact Sciences | 4 | $96 |
| Bayer | 4 | $77 |
| Novartis | 4 | $71 |
| Sumitomo Pharma America, Inc. | 2 | $55 |
| Phathom Pharmaceuticals, Inc. | 2 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $47 |
| Johnson & Johnson | 3 | $46 |
| Dexcom, Inc. | 2 | $38 |
| Eisai Inc. | 2 | $38 |
| Shield Therapeutics Inc | 2 | $34 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Boston Scientific | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Abbott | 1 | $18 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Impel Pharmaceuticals Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VIDEO COLONOSCOPE$5,003
- IMAGINA$915
- VIDEO GASTROSCOPE$817
- VIDEO PROCESSOR$465
- Epclusa$125
How this compares
$10,643 in reported general payments places this provider in the 95th percentile of 2,395 medical providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 45 | $39,428 |
| JardianceEmpagliflozin | 30 | $33,161 |
| XareltoRivaroxaban | 21 | $24,248 |
| EliquisApixaban | 20 | $21,553 |
| MounjaroTirzepatide | 18 | $19,100 |
| RybelsusSemaglutide | 17 | $16,260 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 16 | $13,447 |
| FarxigaDapagliflozin Propanediol | 13 | $11,675 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 11 | $7,844 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 16 | $6,701 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 13 | $1,961 |
| Rosuvastatin Calcium | 132 | $1,883 |
| Levothyroxine Sodium | 92 | $1,454 |
| Omeprazole | 74 | $1,181 |
| Metoprolol Succinate | 48 | $952 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $203 | $55,68862 claims |
| Boehringer IngelheimJardiance | $170 | $33,16130 claims |
| Johnson & JohnsonXarelto | $46 | $24,24821 claims |
| PfizerEliquis | $223 | $21,55320 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $103 | $20,14732 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $305 | $19,51924 claims |
| Lilly USA, LLCMounjaro | $448 | $19,10018 claims |
| AbbVieSynthroid | $476 | $88111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,395 medical providers in New York.
Other medical in Orchard Park
- Rebecca EllwoodAlbany$565K
- Denisse SerranoCortlandt Manor$255K
- Michele Kissous-HuntNew York$246K
- Laura MaroldoNew York$126K
- Carl ClarkeBrooklyn$116K
- Maureen ThyneNew York$109K
- Gina FriesRochester$106K
- Ilse StraussSmithtown$87K
- Helen AdamsNew York$87K
- Hailey BrickmanNew York$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.